Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBD Reference and Biosimilar Adalimumab Crossover Study
2018-004967-30Phase 4Unknown
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Jan 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of adalimumab in Crohn's disease, sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoints: Maintenance of baseline clinical status at week 24 and Maintenance of baseline clinical status at week 48. Status: unknown.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2018-004967-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004967-30.